140 related articles for article (PubMed ID: 34348529)
1. Genetic Evidence on the Association of Interleukin (IL)-1-Mediated Chronic Inflammation with Airflow Obstruction: A Mendelian Randomization Study.
Yang Z; Schooling CM; Kwok MK
COPD; 2021 Aug; 18(4):432-442. PubMed ID: 34348529
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease.
Mi J; Liu Z; Pei S; Wu X; Zhao N; Jiang L; Zhang Z; Bai X
Int Immunopharmacol; 2022 Sep; 110():109020. PubMed ID: 35843146
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization study of interleukin (IL)-1 family and lung cancer.
Yang Z; Schooling CM; Kwok MK
Sci Rep; 2021 Sep; 11(1):17606. PubMed ID: 34475499
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.
Yuan S; Roos PM; Larsson SC
Eur J Neurol; 2020 Oct; 27(10):1913-1917. PubMed ID: 32441415
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
[TBL] [Abstract][Full Text] [Related]
6. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.
Yuan S; Miao Y; Ruan X; Chen J; Li X; Larsson SC
Front Immunol; 2023; 14():1240754. PubMed ID: 37781392
[TBL] [Abstract][Full Text] [Related]
8. Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer.
Yang Z; Yu R; Deng W; Wang W
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3279-3288. PubMed ID: 34324065
[TBL] [Abstract][Full Text] [Related]
9. Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.
Vandebergh M; Becelaere S; ; Dubois B; Goris A
Front Immunol; 2022; 13():834644. PubMed ID: 35386698
[TBL] [Abstract][Full Text] [Related]
10. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Lu H; Wu PF; Zhang W; Liao X
Front Immunol; 2021; 12():647588. PubMed ID: 33936066
[TBL] [Abstract][Full Text] [Related]
11. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation.
Yuan S; Li X; Lin A; Larsson SC
Semin Arthritis Rheum; 2022 Apr; 53():151958. PubMed ID: 35066242
[TBL] [Abstract][Full Text] [Related]
12. Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study.
Harbaum L; Hennigs JK; Simon M; Oqueka T; Watz H; Klose H
Respir Res; 2021 Jul; 22(1):199. PubMed ID: 34233669
[TBL] [Abstract][Full Text] [Related]
13. A bidirectional Mendelian randomization study investigating the relationship between genetically predicted systemic inflammatory regulators and chronic obstructive pulmonary disease.
Zhang M; Wang S; Guan Q; Wang J; Yan B; Zhang L; Li D
Heliyon; 2024 Jan; 10(1):e24109. PubMed ID: 38268600
[TBL] [Abstract][Full Text] [Related]
14. Potential marker genes for chronic obstructive pulmonary disease revealed based on single-cell sequencing and Mendelian randomization analysis.
Sun G; Zhou Y; Han X; Che X; Yu S; Song D; Ma F; Huang L
Aging (Albany NY); 2024 May; 16(10):8922-8943. PubMed ID: 38787375
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study.
Milne S; Li X; Hernandez Cordero AI; Yang CX; Cho MH; Beaty TH; Ruczinski I; Hansel NN; Bossé Y; Brandsma CA; Sin DD; Obeidat M
Thorax; 2020 Nov; 75(11):934-943. PubMed ID: 32839289
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
Lin J; Wang Y; Wang Y; Pan Y
Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
[No Abstract] [Full Text] [Related]
17. Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study.
Williams JA; Burgess S; Suckling J; Lalousis PA; Batool F; Griffiths SL; Palmer E; Karwath A; Barsky A; Gkoutos GV; Wood S; Barnes NM; David AS; Donohoe G; Neill JC; Deakin B; Khandaker GM; Upthegrove R;
JAMA Psychiatry; 2022 May; 79(5):498-507. PubMed ID: 35353173
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and heart failure: a two-sample Mendelian randomization study.
Remmelzwaal S; van Oort S; Handoko ML; van Empel V; Heymans SRB; Beulens JWJ
J Cardiovasc Med (Hagerstown); 2022 Nov; 23(11):728-735. PubMed ID: 36166332
[TBL] [Abstract][Full Text] [Related]
19. The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
Wu D; Wong P; Lam SHM; Li EK; Qin L; Tam LS; Gu J
Rheumatology (Oxford); 2021 Apr; 60(4):1963-1973. PubMed ID: 33188428
[TBL] [Abstract][Full Text] [Related]
20. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
